Actively Recruiting
Prospective Screening for Breast Cancer-related Lymphedema
Led by Massachusetts General Hospital · Updated on 2025-12-24
10000
Participants Needed
1
Research Sites
904 weeks
Total Duration
On this page
Sponsors
M
Massachusetts General Hospital
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary objectives of this study are twofold: 1) to detect and determine the level of symptoms, functional disability, and changes in quality of life that breast cancer patients experience from changes in their arms during and after treatment for breast cancer by collecting patient reported outcome measures, objective measurements, and clinical information in a prospectively maintained database and 2) to improve breast cancer-related lymphedema outcomes by early detection using objective measurements and symptoms assessments and assess these outcomes by maintaining the data in a database in order to contribute to the literature. The secondary aim of this study is to assess extracellular fluid content in the upper extremity, breast, and/or trunk of patients treated for breast cancer before, during, and after treatment in order to better understand the role of bioimpedance spectroscopy in lymphedema screening.
CONDITIONS
Official Title
Prospective Screening for Breast Cancer-related Lymphedema
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of breast cancer
- Ability to position arm for perometry measurements (e.g., shoulder abducted to 90 degrees)
- Ability to stand unaided for bioimpedance spectroscopy (BIS) measurements
You will not qualify if you...
- Evidence of distant metastatic disease causing edema
- Previous breast cancer
- History of lymphedema
- Pregnancy at time of enrollment
- Presence of cardiac implants (contraindications for BIS)
- Medical conditions causing fluid retention or swelling (e.g., axillary cancer recurrence, renal insufficiency, congestive heart failure)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02134
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here